Correlation Between Pmv Pharmaceuticals and Compass Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Compass Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Compass Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Compass Therapeutics, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Compass Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Compass Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Compass Therapeutics.
Diversification Opportunities for Pmv Pharmaceuticals and Compass Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pmv and Compass is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Compass Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Compass Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Compass Therapeutics go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Compass Therapeutics
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Compass Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 4.59 times less risky than Compass Therapeutics. The stock trades about -0.24 of its potential returns per unit of risk. The Compass Therapeutics is currently generating about 0.36 of returns per unit of risk over similar time horizon. If you would invest 151.00 in Compass Therapeutics on October 24, 2024 and sell it today you would earn a total of 110.00 from holding Compass Therapeutics or generate 72.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Compass Therapeutics
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Compass Therapeutics |
Pmv Pharmaceuticals and Compass Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Compass Therapeutics
The main advantage of trading using opposite Pmv Pharmaceuticals and Compass Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Compass Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Therapeutics will offset losses from the drop in Compass Therapeutics' long position.| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
| Compass Therapeutics vs. Ideaya Biosciences | Compass Therapeutics vs. AnaptysBio | Compass Therapeutics vs. MeiraGTx Holdings PLC | Compass Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |